Neothetics’ Belly-Busting Shot Lipo-202 Enters Phase 3 Trials
The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.
The lipodissolving injectable category amps up as Neothetics’ tummy tamer enters Phase 3 trials. Stay tuned.
Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.